Table 3.
Additional genes related to apoptosis and the Major Histocompatibility Complex shown to be up-regulated in MSI-H colorectal cancer in comparison to MSS cancers.
| Apoptosis related genes up-regulated in MSI-H colorectal cancers (P < 0.005, Benjamini and Hochberg False Discovery Rate) | |
| Gene name | Fold change |
| TNF-induced protein | 1.9 |
| Tumour necrosis factor receptor superfamily 10d | 1.9 |
| Tumour necrosis factor receptor superfamily 9 | 1.7 |
| Tumour necrosis factor receptor superfamily 10b | 1.7 |
| Tumour necrosis factor receptor superfamily 6 | 1.6 |
| Death-associated protein kinase 1 | 1.5 |
| DNA fragmentation factor, beta polypeptide (caspase-activated DNase) | 1.4 |
| Bcl-2-related protein A1 | 2.2 |
| Bcl-2/adenovirus E1B 19 kDa interacting protein 3-like | 1.8 |
| Bcl-2 antagonist/killer | 1.4 |
| Bcl-2 associated athanogene 3 | 1.4 |
| Bcl-2/adenovirus E1B 19 kDa interacting protein 1 | 1.2 |
| Baculoviral IAP repeat-containing 3 | 1.6 |
| Baculoviral IAP repeat-containing 2 | 1.2 |
| Chemokine (C-X-C motif) receptor 4 | 1.8 |
| CD27-binding (Siva) protein | 1.5 |
| Thioredoxin-like, 32 kDa | 1.4 |
| Mitogen-activated protein kinase kinase kinase 5 | 1.4 |
| Microtubule associated protein tau | 1.4 |
| Macrophage erythroblast attacher | 1.3 |
| Testis enhanced gene transcript (BAX inhibitor 1) | 1.2 |
| Major histocompatibility complex-related genes up-regulated in MSI-H colorectal cancer (P < 0.05, Benjamini and Hochberg False Discovery Rate) | |
| Gene name | Fold change |
| Major histocompatibility complex, class II, DR alpha | 2.0 |
| Major histocompatibility complex, class II, DQ beta 1 | 1.8 |
| Major histocompatibility complex, class II, DP alpha 1 | 1.8 |
| H. sapiens HLA-DMA gene | 1.7 |
| Major histocompatibility complex, class II, DR beta 1 | 1.6 |
| Major histocompatibility complex, class II, DR beta 5 | 1.5 |
| HLA-B associated transcript 1 | 1.2 |
| Major histocompatibility complex, class I, C | 1.2 |